- Nijenhuis et al - POPular TAVI trial - Bleeding reduction post-TAVI with OAC alone vs OAC + clopidogrel
- Ramlawi et al - TAVR safe and effective in low-risk bicuspid aortic stenosis patients
- Desai et al - STS/ACC TVT Registry - TAVR model reveals differences in hospital outcomes
- Alexander et al - AUGUSTUS trial - Apixaban preferred over aspirin in AF patients with recent ACS/PCI
- Hiatt et al - Subgroup analysis VOYAGER PAD
- Kim et al - No role for sodium nitrite in out-of-hospital cardiac arrest
Posted on
Previous Article
« ACC.20/WCC Highlights Podcast Part 3 of 3 Next Article
ACC.20/WCC Highlights Podcast Part 1 of 3 »
« ACC.20/WCC Highlights Podcast Part 3 of 3 Next Article
ACC.20/WCC Highlights Podcast Part 1 of 3 »
Table of Contents: ACC/WCC 2020
Featured articles
Heart Failure and Cardiomyopathies
Mavacamten shows promising results in non-obstructive hypertrophic cardiomyopathy
Vericiguat shows beneficial effects in a very high-risk HF population
No role for sodium nitrite in out-of-hospital cardiac arrest
Vascular Medicine and Thromboembolism
Rivaroxaban and aspirin effective and safe for PAD patients
TAILOR-PCI misses endpoint but still provides valuable insights
Edoxaban: alternative to warfarin after surgical aortic or mitral valve procedures?
Bleeding reduction post-TAVI with OAC alone vs OAC + clopidogrel
Apixaban offers new perspective for cancer patients in need of anticoagulation
Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery
Interventional Cardiology
TAVR safe and effective in low-risk bicuspid aortic stenosis patients
TAVR model reveals differences in hospital outcomes
2-year results show non-significant outcomes TAVR vs surgery in severe aortic stenosis
Renal denervation better than sham for blood pressure
Infusion of ethanol in the vein of Marshall for persistent AF
Atrial Fibrillation/Acute Coronary Syndrome
Fewer adverse events with ticagrelor monotherapy after 3 months DAPT
TWILIGHT sub-study: same outcomes for diabetes patients
TWILIGHT sub-study: complex PCI patients
LAAO Watchman registry data positive
Apixaban in AF patients with recent ACS/PCI: Drop aspirin after 30 days
Genetics and Prevention
Homozygous FH responds to alirocumab
Evinacumab significantly reduces LDL-C in homozygous FH patients
Higher serum levels of eicosapentaenoic acid correlate with reduced CV events
Quit smoking: vaping + counselling helps
Related Articles
September 8, 2020
LAAO Watchman registry data positive
September 8, 2020
Homozygous FH responds to alirocumab
September 8, 2020
Infusion of ethanol in the vein of Marshall for persistent AF
© 2023 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy